Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Arctic Bioscience AS ( (DE:9TD) ) is now available.
Arctic Bioscience announced a significant increase in its share capital following the exercise of debt conversion rights, resulting in the issuance of over 1.3 million new shares. This move is expected to strengthen the company’s financial position and support its ongoing development efforts, particularly in the treatment of psoriasis, enhancing its market presence and offering potential benefits to stakeholders.
More about Arctic Bioscience AS
Arctic Bioscience is a biotech company that specializes in developing and commercializing pharmaceutical and nutraceutical products derived from unique bioactive marine compounds. The company is working on HRO350, an innovative oral drug candidate aimed at treating mild-to-moderate psoriasis, and offers nutraceuticals globally under the ROMEGA® brand.
YTD Price Performance: 66.92%
Average Trading Volume: 1,500
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €6.79M
Learn more about 9TD stock on TipRanks’ Stock Analysis page.
